[HTML][HTML] Research Progress on Structure and Anti-Gynecological Malignant Tumor of Shikonin

LN Ke, LQ Kong, HH Xu, QH Chen, Y Dong, B Li… - Frontiers in …, 2022 - frontiersin.org
Gynecological malignancy seriously threatens the physical and mental health of women.
Shikonin is a naphthoquinone compound with a variety of biological activities. Studies have …

Design, synthesis and mechanism of novel shikonin derivatives as potent anticancer agents

SK Baloch, L Ma, XL Wang, J Shi, Y Zhu, FY Wu… - Rsc Advances, 2015 - pubs.rsc.org
In this study, a series of novel shikonin derivatives (30–49) were designed and synthesized
and their anti-proliferative activities were evaluated against five different cancer cell lines …

Synthesis and biological evaluation of novel shikonin ester derivatives as potential anti-cancer agents

SK Baloch, LJ Ling, HY Qiu, L Ma, HY Lin, SC Huang… - RSC …, 2014 - pubs.rsc.org
Shikonin has previously been reported to function as a potent anti-cancer drug that induces
cell apoptosis via diverse pathways. To optimize the effectiveness of its pro-apoptotic …

Pharmacological properties and derivatives of shikonin—A review in recent years

C Guo, J He, X Song, L Tan, M Wang, P Jiang… - Pharmacological …, 2019 - Elsevier
Shikonin is the major bioactive component extracted from the roots of Lithospermum
erythrorhizon which is also known as “Zicao” in Traditional Chinese Medicine (TCM). Recent …

Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment

Q Wang, J Wang, J Wang, X Ju, H Zhang - Toxicology Research, 2021 - academic.oup.com
Shikonin is one of the major bioactive components of Lithospermum erythrorhizon. It has a
good killing effect in a variety of tumor cells. Its antitumor effect involves multiple targets and …

Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms …

M Valipour - European journal of medicinal chemistry, 2022 - Elsevier
Shikonin and its enantiomeric analogue, alkaninn, are prevailing natural lead compounds in
the drug discovery and development of anticancer agents. Despite having numerous …

Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathway

Y Ma, X Yang, H Han, Z Wen, M Yang, Y Zhang, J Fu… - Bioorganic …, 2021 - Elsevier
Triple-negative breast cancer (TNBC) has an unfavorable prognosis attribute to its low
differentiation, rapid proliferation and high distant metastasis rate. PI3K/Akt/mTOR as an …

[HTML][HTML] Shikonin inhibits the proliferation of cervical cancer cells via FAK/AKT/GSK3β signalling

Z Xu, L Huang, T Zhang, Y Liu, F Fang… - Oncology …, 2022 - spandidos-publications.com
Cervical cancer is one of the most lethal malignancies of the female reproductive system.
Shikonin, a naphthoquinone pigment extracted from the traditional medicinal herb …

Synthesis, biological function and evaluation of Shikonin in cancer therapy

F Wang, X Yao, Y Zhang, J Tang - Fitoterapia, 2019 - Elsevier
Shikonin is a natural compound isolated from herbs and traditional medicines that have
been used in a number of countries to treat various illnesses including inflammation, virus …

[HTML][HTML] Shikonin induces apoptosis and inhibits migration of ovarian carcinoma cells by inhibiting the phosphorylation of Src and FAK

Z Hao, J Qian, J Yang - Oncology letters, 2015 - spandidos-publications.com
The present study identified that shikonin, a naphthoquinone extracted from the roots of
Lithospermum erythrorhizon, inhibits the migration of ovarian cancer cells and induces their …